XTX Topco Ltd acquired a new stake in Perrigo Company plc (NYSE:PRGO - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 50,341 shares of the company's stock, valued at approximately $1,412,000.
A number of other institutional investors also recently bought and sold shares of the business. State of Michigan Retirement System increased its position in Perrigo by 1.2% during the first quarter. State of Michigan Retirement System now owns 32,658 shares of the company's stock worth $916,000 after purchasing an additional 400 shares during the last quarter. State of Alaska Department of Revenue lifted its position in shares of Perrigo by 2.8% in the 1st quarter. State of Alaska Department of Revenue now owns 15,984 shares of the company's stock worth $448,000 after buying an additional 430 shares during the last quarter. Linden Thomas Advisory Services LLC increased its holdings in shares of Perrigo by 3.8% in the 1st quarter. Linden Thomas Advisory Services LLC now owns 19,707 shares of the company's stock worth $553,000 after acquiring an additional 724 shares during the period. Snowden Capital Advisors LLC increased its stake in Perrigo by 3.6% during the 4th quarter. Snowden Capital Advisors LLC now owns 24,337 shares of the company's stock valued at $626,000 after buying an additional 842 shares during the period. Finally, Fifth Third Bancorp grew its stake in shares of Perrigo by 62.0% in the 1st quarter. Fifth Third Bancorp now owns 2,218 shares of the company's stock worth $62,000 after purchasing an additional 849 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.
Perrigo Stock Up 0.1%
NYSE PRGO traded up $0.02 during trading hours on Friday, reaching $26.69. 1,115,239 shares of the company's stock were exchanged, compared to its average volume of 864,587. The company's 50-day moving average is $27.01 and its two-hundred day moving average is $26.32. Perrigo Company plc has a one year low of $23.14 and a one year high of $30.93. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.28 and a current ratio of 2.36. The company has a market capitalization of $3.67 billion, a price-to-earnings ratio of -20.37 and a beta of 0.47.
Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.56 by $0.04. The company had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.09 billion. Perrigo had a positive return on equity of 8.93% and a negative net margin of 4.16%. The firm's revenue for the quarter was down 3.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.29 EPS. On average, analysts forecast that Perrigo Company plc will post 2.56 EPS for the current fiscal year.
Perrigo Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 16th. Investors of record on Friday, August 29th will be paid a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date of this dividend is Friday, August 29th. Perrigo's payout ratio is currently -88.55%.
Analyst Ratings Changes
Separately, Wall Street Zen cut shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, Perrigo presently has an average rating of "Hold" and a consensus target price of $33.00.
Read Our Latest Analysis on Perrigo
About Perrigo
(
Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Further Reading

Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.